China Resources Pharmaceutical Group Ltd. (HK:3320) has released an update.
China Resources Pharmaceutical Group Ltd. has announced the composition of its Board of Directors, which includes Han Yuewei as Chairman and Non-Executive Director, Bai Xiaosong as the CEO, and a lineup of executive, non-executive, and independent non-executive directors. The company also detailed five board committees and their respective members, showcasing the governance structure that supports its operations.
For further insights into HK:3320 stock, check out TipRanks’ Stock Analysis page.
